Preview
For the past half century, diabetes therapy has fluctuated between loose control and tight control. The present trend toward tight control is an attempt to delay or prevent long-term complications and reduce associated morbidity and mortality. But, is tight control desirable for all patients? Dr Ainslie presents an appraisal of old and new diabetes therapies and suggests a cautious approach to tight-control regimens.